glp-1 reimbursement news glp 1 SEA: receptor agonists have become key in managing metabolic disease, however rising use raises urgent questions about Rebates Drive U.S. Payer Coverage

SURMOUNT-3 evaluated the efficacy and safety of tirzepatide compared to placebo for 72 weeks after a 12-week intensive lifestyle intervention lead-in period that included a low-calorie diet and exercise

In the obesity group, there was a significant and clinically meaningful reduction in body weight of 4.74% at week 8, with weight continuously decreasing during the 8-week treatment period

But the lack of FDA oversight can result in the ingredients being too strong, not strong enough or even harmful to your health

While rare, more severe side effects can include pancreatitis, allergic reactions, kidney damage, gallstones, and others.Your medical specialist at Gameday Mens Health will thoroughly discuss the potential side effects with you and answer any questions you might have regarding the injections

September 24, 2025

If youre sensitive to sudden stimulation or feel peaks and crashes easily, Vyvanse may be the better choice